Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Shopify Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Shopify Inc. trades at $169.06 (market cap $227.12B). The key difference: Shopify Inc. is far larger — about 26.8× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Shopify Inc. for 78 Days on average.
| HNGE | SHOP | |
|---|---|---|
Market Cap | $8.48B | $227.12B |
Volume | 879,799 | 6,965,160 |
Sector | Health | Technology |
52-Week High | $105.14 | $179.22 |
52-Week Low | $31.17 | $95.40 |
Typical Hold Time | 0 Days | 78 Days |
Enterprise Value | $8.10B | $222.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
SHOP trades at $172.50, down 3.75% today but maintains a bullish technical outlook with strong moving average support. The company shows robust revenue growth from $5.6B in 2022 to $11.6B in 2025, though valuation ratios remain elevated with a P/E of 119.27. Recent news highlights Shopify's AI innovations including Canvas site-building tool and open AI agent checkout, positioning it favorably against competitors.
Shopify's outlook remains positive with 67% analyst buy ratings and $172.47 consensus target. Key opportunities include AI-driven commerce expansion and merchant solutions growth accelerating to 37%. Risks include high valuation multiples and competitive pressure from Amazon's opposing AI strategy. The stock offers growth potential but requires monitoring of earnings sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
